Market News AIOpen the app

OBX stock news · Obsidian Therapeutics, Inc.

Stories about Obsidian Therapeutics, Inc. (OBX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for OBX

Follow Obsidian Therapeutics, Inc. (OBX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for OBX
Free on the App Store and Google Play, or on the web.
  1. Nov 12, 2026, 4:53 PM ET · Market

    Obsidian Therapeutics shared its third-quarter results, showing a 67% success rate in its melanoma study and strong cash reserves.

    Good for OBX

    Obsidian reported a 67% response rate for amsoki-cel among 15 patients and $324.4 million in cash. The results support a favorable read, though the small study needs confirmation.